Mirikizumab (Crohn’s disease); Addendum to Project A25-42 (dossier assessment)
Fields of Study & Subjects
Inflammatory Bowel Disease
Health Systems
Economic Evaluations
Quality of Life
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
- Publication date
- 19 January 2026
- Language
- EN